Gurgaon: A 46-year-old woman with comorbidities like coronary artery disease, hypertension and congenital heart defects died after testing Covid-positive on Monday, four days after she was admitted on December 28.
This was the first Covid death the city reported since May 11 last year, when a 76-year-old fully vaccinated woman with comorbidities such as chronic kidney and lung disease and hypertension died.
The patient who succumbed on Monday, a resident of DLF 1, was fully vaccinated too. She was hospitalised due to shortness of breath, fever and cough and tested positive for Covid in hospital.
“The patient was given IV fluids, antibiotics, oxygen support and other supportive measures. Later, she developed bradycardia, followed by a cardiac arrest. CPR was initiated but she could not be revived,” an official from the hospital where she was treated said.
The health department said the death happened due to her comorbidities, not Covid. “Since the patient was also Covid-positive, it has been declared as a Covid death. We sent 20 samples for genome sequencing and have so far got the results of six. They are all Omicron. There is no need to panic,” said Virender Yadav, the chief medical officer (CMO).
So far, 1,037 patients have died of Covid in the city, of whom 711 had comorbidities.
The CMO added that testing has been ramped up. “There is a slight rise in cases, but we are yet to confirm if that is because of the JN.1 sub-variant. Patients are recovering in home isolation,” Yadav said.
Meanwhile, the city recorded two new Covid cases on Monday. It has five active cases at present, all in home isolation. Two patients recovered on Monday, while 115 samples were tested for Covid. The positivity rate was 1.7%.
The Haryana health department last month directed all hospitals to review public health and hospital preparedness measures in the wake of a rise in Covid cases in some of the states.
JN.1 (BA.2.86.1.1), a new sub-variant of Covid first detected in the country in a 79-year-old woman in Kerala, is of particular concern now. It is a descendant of the BA.2.86 lineage (Pirola) of SARS-CoV-2, first identified in August.
Reports suggest it carries significant mutations that might contribute to increased transmissibility and immune-escape ability. The US, China, and Singapore have also reported JN.1 cases.
Last May, the WHO declared Covid was no longer a global public health emergency.
Experts said while JN.1 might pose increased transmission risks, a proactive approach in following established preventive guidelines could contribute significantly to controlling its spread, even in areas with few cases.



Source link